Implementation of the national standardized german medication plan to detect drug related problems: results from the metropolmediplan2016 – mmp16

  • At: 2017 FIP Congress in Seoul (South Korea)
  • Type: Poster
  • By: ABBAS, Zahra (Friedrich-Alexander-University Erlangen-Nuremberg, Molecular and Clinical Pharmacy, Erlangen, Germany)
  • Co-author(s): Zahra Abbas: Chemistry and Pharmacy, Molecular and Clinical Pharmacy, Erlangen, Germany
    Simone Schächtele: Clinical Pharmacology, Institute of Experimental and Clinical Pharmacology and Toxicology, Erlangen, Germany
    Susanne Schuster: Department of Emergency Medicine , Hospital Fürth, Fürth, Germany
    Martin Sedlmayr: Medical Informatics, Institute for Medical Informatics, Erlangen, Germany
    Frank Dörje: Erlangen University Hospital, Erlangen, Germany
    H. U. Prokosch: Medical Informatics, Institute for Medical Informatics, Erlangen, Germany
    Harald Dormann: Department of Emergency Medicine, Hospital Fürth, Fürth, Germany
    Martin Fromm: Clinical Pharmacology, Institute of Experimental and Clinical Pharmacology and Toxicology, Erlangen, Germany
    Renke Maas: Clinical Pharmacology, Institute of Experimental and Clinical Pharmacology and Toxicology, Erlangen, Germany
    Kristina Friedland: Chemistry and Pharmacy, Molecular and Clinical Pharmacy, Erlangen, Germany
  • Abstract:

    Methods

    The MMP16 consortium consists of different experts. An interdisciplinary team including clinical pharmacists and clinical pharmacologists evaluated a random sample of 300 anonymized medication plans, generated under clinical routine conditions. The aim was to investigate if the medication plans were formally complete and suitable..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login